|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.83 USD | +1.66% |
|
+21.27% | -0.77% |
| Apr. 15 | Tango Therapeutics, Inc. Announces Leadership Appointments | CI |
| Apr. 01 | Zymeworks Inc. Announces Executive Changes, Effective from April 1, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 13.02 | 14.99 | 14.35 |
| Spread/Res. | -1.42% | -14.41% | -10.59% |
| Spread/Supp. | +9.10% | +27.92% | +26.53% |
| Support | 11.76 | 10.03 | 10.14 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NVCR Stock
- Charts NovoCure Limited
Select your edition
All financial news and data tailored to specific country editions
